Document Type
Article
Version Deposited
Published Version
Open Access Funding Source
Open Access Publishing Fund
Publication Date
4-21-2023
Publication Title
Frontiers in Psychiatry
DOI
10.3389/fpsyt.2023.1172754
Abstract
Post-traumatic stress disorder is a debilitating chronic illness that affects 6 out of 100 adults after a severe trauma. The alpha-adrenergic antagonist prazosin, which is prescribed off-label for flashbacks and nightmares due to trauma, is often continued indefinitely due to reports of symptoms returning upon discontinuation. There is no standard guidance for a trial of discontinuation of prazosin due to intolerance or side effects. In this case series, three patients are started on prazosin leading to remission of trauma-related symptoms, and symptoms continue to remit after treatment for an average of about 2 years followed by discontinuation of the medication. There are many similarities in these case reports which serve to provide guidance as to when a trial of prazosin discontinuation may be warranted.
Recommended Citation
Richardson C, Yuh J, Su J, Forsberg M. Case series: Continued remission of PTSD symptoms after discontinuation of prazosin. Frontiers in Psychiatry. 2023 Apr 21;14:1172754. doi: 10.3389/fpsyt.2023.1172754. PMID: 37151970. PMCID: PMC10162405.
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.
Included in
Heterocyclic Compounds Commons, Pathological Conditions, Signs and Symptoms Commons, Psychiatric and Mental Health Commons, Psychiatry Commons, Psychiatry and Psychology Commons, Therapeutics Commons
Comments
Copyright © 2023 Richardson, Yuh, Su and Forsberg.
Publication of this article was supported by the 2022-23 Rowan University Libraries Open Access Publishing Fund.